Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


Articles published in AJR Am J Roentgenol

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    June 2018
  1. NIU XK, Chen XH, Chen ZF, Chen L, et al
    Diagnostic Performance of Biparametric MRI for Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 Jun 12:1-10. doi: 10.2214/AJR.17.18946.
    PubMed     Text format     Abstract available


  2. ORTMAN M, Kasson M, Sidana A
    Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2018;210:W268.
    PubMed     Text format    


  3. SHERIDAN AD, Weinreb JC, Spektor M
    Reply to "Prostate Cancer and Prostate Imaging Reporting and Data System Category 3 Lesions Identified at Multiparametric Prostate MRI".
    AJR Am J Roentgenol. 2018;210:W269.
    PubMed     Text format    


    May 2018
  4. SI Y, Liu RB
    Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2018 May 29:1-11. doi: 10.2214/AJR.17.18934.
    PubMed     Text format     Abstract available


    April 2018
  5. KIM JG, Kim CK, Kim JH
    Prebiopsy Multiparametric MRI With Cancer-Negative Findings in Men With Suspected Prostate Cancer: Evaluation Using Prostate Imaging Reporting and Data System Version 2.
    AJR Am J Roentgenol. 2018 Apr 30:1-6. doi: 10.2214/AJR.17.18926.
    PubMed     Text format     Abstract available


  6. LEE MS, Moon MH, Kim YA, Sung CK, et al
    Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
    AJR Am J Roentgenol. 2018 Apr 27:1-7. doi: 10.2214/AJR.17.18684.
    PubMed     Text format     Abstract available


    March 2018
  7. TANEJA S, Jena A, Taneja R, Singh A, et al
    Effect of Combined (68)Ga-PSMAHBED-CC Uptake Pattern and Multiparametric MRI Derived With Simultaneous PET/MRI in the Diagnosis of Primary Prostate Cancer: Initial Experience.
    AJR Am J Roentgenol. 2018 Mar 12:1-8. doi: 10.2214/AJR.17.18881.
    PubMed     Text format     Abstract available


    January 2018
  8. WOO S, Suh CH, Kim SY, Cho JY, et al
    The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis.
    AJR Am J Roentgenol. 2018 Jan 30:W1-W15. doi: 10.2214/AJR.17.18481.
    PubMed     Text format     Abstract available


  9. METSER U, Berlin A, Halankar J, Murphy G, et al
    (18)F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer.
    AJR Am J Roentgenol. 2018 Jan 11:1-6. doi: 10.2214/AJR.17.18567.
    PubMed     Text format     Abstract available


    December 2017
  10. NIU XK, Chen ZF, Chen L, Li J, et al
    Clinical Application of Biparametric MRI Texture Analysis for Detection and Evaluation of High-Grade Prostate Cancer in Zone-Specific Regions.
    AJR Am J Roentgenol. 2017 Dec 8:W1-W8. doi: 10.2214/AJR.17.18494.
    PubMed     Text format     Abstract available


    November 2017
  11. SHERIDAN AD, Nath SK, Syed JS, Aneja S, et al
    Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2017 Nov 7:1-11. doi: 10.2214/AJR.17.18516.
    PubMed     Text format     Abstract available


    October 2017
  12. TAMADA T, Huang C, Ream JM, Taffel M, et al
    Apparent Diffusion Coefficient Values of Prostate Cancer: Comparison of 2D and 3D ROIs.
    AJR Am J Roentgenol. 2017 Oct 18:1-5. doi: 10.2214/AJR.17.18495.
    PubMed     Text format     Abstract available


  13. KRISHNA S, McInnes M, Lim C, Lim R, et al
    Comparison of Prostate Imaging Reporting and Data System Versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    AJR Am J Roentgenol. 2017 Oct 5:W1-W9. doi: 10.2214/AJR.17.17964.
    PubMed     Text format     Abstract available


    September 2017
  14. WOO S, Suh CH, Kim SY, Cho JY, et al
    Head-To-Head Comparison Between High- and Standard-b-Value DWI for Detecting Prostate Cancer: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2017 Sep 27:1-10. doi: 10.2214/AJR.17.18480.
    PubMed     Text format     Abstract available


    August 2017
  15. FELKER ER, Raman SS, Margolis DJ, Lu DSK, et al
    Risk Stratification Among Men With Prostate Imaging Reporting and Data System Version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary?
    AJR Am J Roentgenol. 2017 Aug 31:1-6. doi: 10.2214/AJR.17.18008.
    PubMed     Text format     Abstract available


  16. WU CJ, Zhang YD, Bao ML, Li H, et al
    Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
    AJR Am J Roentgenol. 2017 Aug 23:1-7. doi: 10.2214/AJR.16.17781.
    PubMed     Text format     Abstract available


  17. WOO S, Suh CH, Kim SY, Cho JY, et al
    Shear-Wave Elastography for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-Analysis.
    AJR Am J Roentgenol. 2017 Aug 10:1-9. doi: 10.2214/AJR.17.18056.
    PubMed     Text format     Abstract available


  18. JADVAR H
    Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.
    AJR Am J Roentgenol. 2017;209:277-288.
    PubMed     Text format     Abstract available


    July 2017
  19. SHERIDAN AD, Nath SK, Huber S, Rosasco S, et al
    Role of MRI in the Use of an Absorbable Hydrogel Spacer in Men Undergoing Radiation Therapy for Prostate Cancer: What the Radiologist Needs to Know.
    AJR Am J Roentgenol. 2017 Jul 25:1-3. doi: 10.2214/AJR.17.18026.
    PubMed     Text format     Abstract available


  20. KIM SH, Choi MS, Kim MJ, Kim YH, et al
    Validation of Prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in Prostate Cancer Diagnosis.
    AJR Am J Roentgenol. 2017 Jul 13:1-6. doi: 10.2214/AJR.16.17629.
    PubMed     Text format     Abstract available


    June 2017
  21. GLAZER DI, Mayo-Smith WW, Sainani NI, Sadow CA, et al
    Interreader Agreement of Prostate Imaging Reporting and Data System Version 2 Using an In-Bore MRI-Guided Prostate Biopsy Cohort: A Single Institution's Initial Experience.
    AJR Am J Roentgenol. 2017 Jun 28:W1-W7. doi: 10.2214/AJR.16.17551.
    PubMed     Text format     Abstract available


  22. MORGAN VA, Parker C, MacDonald A, Thomas K, et al
    Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
    AJR Am J Roentgenol. 2017 Jun 13:1-9. doi: 10.2214/AJR.17.17790.
    PubMed     Text format     Abstract available


  23. GANESHAN D, Aparicio AM, Morani A, Kundra V, et al
    Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.
    AJR Am J Roentgenol. 2017 Jun 7:1-6. doi: 10.2214/AJR.16.17214.
    PubMed     Text format     Abstract available


  24. MATSUOKA Y, Ishioka J, Tanaka H, Kimura T, et al
    Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer.
    AJR Am J Roentgenol. 2017 Jun 1:W1-W9. doi: 10.2214/AJR.16.17163.
    PubMed     Text format     Abstract available


  25. PURYSKO AS, Bittencourt LK, Bullen JA, Mostardeiro TR, et al
    Accuracy and Interobserver Agreement for Prostate Imaging Reporting and Data System, Version 2, for the Characterization of Lesions Identified on Multiparametric MRI of the Prostate.
    AJR Am J Roentgenol. 2017 Jun 1:1-7. doi: 10.2214/AJR.16.17289.
    PubMed     Text format     Abstract available


    April 2017
  26. SEO JW, Shin SJ, Taik Oh Y, Jung DC, et al
    PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer.
    AJR Am J Roentgenol. 2017 Apr 18:W1-W9. doi: 10.2214/AJR.16.16981.
    PubMed     Text format     Abstract available


    March 2017
  27. LIM CS, McInnes MD, Flood TA, Breau RH, et al
    Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy.
    AJR Am J Roentgenol. 2017 Mar 7:1-8. doi: 10.2214/AJR.16.16843.
    PubMed     Text format     Abstract available


    February 2017
  28. VENDERINK W, Govers TM, de Rooij M, Futterer JJ, et al
    Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
    AJR Am J Roentgenol. 2017 Feb 22:1-6. doi: 10.2214/AJR.16.17322.
    PubMed     Text format     Abstract available


    January 2017
  29. HABIBIAN DJ, Liu CC, Dao A, Kosinski KE, et al
    Imaging Characteristics of Prostate Cancer Patients Who Discontinued Active Surveillance on 3-T Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2017 Jan 11:1-6. doi: 10.2214/AJR.16.16822.
    PubMed     Text format     Abstract available


    December 2016
  30. ROSENKRANTZ AB, Ayoola A, Hoffman D, Khasgiwala A, et al
    The Learning Curve in Prostate MRI Interpretation: Self-Directed Learning Versus Continual Reader Feedback.
    AJR Am J Roentgenol. 2016 Dec 27:W1-W9. doi: 10.2214/AJR.16.16876.
    PubMed     Text format     Abstract available


    October 2016
  31. BARRETT T, Haider MA
    The Emerging Role of MRI in Prostate Cancer Active Surveillance and Ongoing Challenges.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  32. HAROON A, Ahmed HU, Cathcart P, Almuhaideb A, et al
    18F-FECH PET/CT to Assess Clinically Significant Disease in Prostate Cancer: Correlation With Maximum and Total Cancer Core Length Obtained via MRI-Guided Template Mapping Biopsies.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  33. KIRSCH AJ, Coakley FV, Foster BR
    A Modified Approach for Transgluteal Prostate Biopsy in Patients Without Rectal Access.
    AJR Am J Roentgenol. 2016;207:W20.
    PubMed     Text format    


    July 2016
  34. ROSENKRANTZ AB, Oto A, Turkbey B, Westphalen AC, et al
    Reply to "Standardizing Biparametric MRI to Simplify and Improve Prostate Imaging Reporting and Data System, Version 2, in Prostate Cancer Management".
    AJR Am J Roentgenol. 2016.
    PubMed     Text format    


  35. SCIALPI M, Martorana E, D'Andrea A
    Standardizing Biparametric MRI to Simplify and Improve Prostate Imaging Reporting and Data System, Version 2, in Prostate Cancer Management.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format    


    June 2016
  36. SADINSKI M, Karczmar G, Peng Y, Wang S, et al
    Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  37. ZHANG YD, Wu CJ, Bao ML, Li H, et al
    New RESOLVE-Based Diffusional Kurtosis Imaging in MRI-Visible Prostate Cancer: Effect of Reduced b Value on Image Quality and Diagnostic Effectiveness.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


  38. ROSENKRANTZ AB, Pujara AC, Taneja SS
    Use of a Quality Improvement Initiative to Achieve Consistent Reporting of Level of Suspicion for Tumor on Multiparametric Prostate MRI.
    AJR Am J Roentgenol. 2016;206:1040-4.
    PubMed     Text format     Abstract available


    April 2016
  39. WOO S, Kim SY, Cho JY, Kim SH, et al
    Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


  40. GUPTA RT, Brown AF, Silverman RK, Tay KJ, et al
    Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


  41. WOO S, Kim SY, Kim SH, Cho JY, et al
    JOURNAL CLUB: Identification of Bone Metastasis With Routine Prostate MRI: A Study of Patients With Newly Diagnosed Prostate Cancer.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


  42. ROZENBERG R, Thornhill RE, Flood TA, Hakim SW, et al
    Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
    AJR Am J Roentgenol. 2016;206:775-82.
    PubMed     Text format     Abstract available


    March 2016
  43. MCCANN SM, Jiang Y, Fan X, Wang J, et al
    Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study.
    AJR Am J Roentgenol. 2016;206:559-65.
    PubMed     Text format     Abstract available


    February 2016
  44. ROSENKRANTZ AB, Oto A, Turkbey B, Westphalen AC, et al
    Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


  45. HOTKER AM, Mazaheri Y, Aras O, Zheng J, et al
    Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  46. SCHIMMOLLER L, Blondin D, Arsov C, Rabenalt R, et al
    MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
    AJR Am J Roentgenol. 2016;206:92-9.
    PubMed     Text format     Abstract available


    December 2015
  47. ROSENKRANTZ AB, Ream JM, Nolan P, Rusinek H, et al
    Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
    AJR Am J Roentgenol. 2015;205:1208-14.
    PubMed     Text format     Abstract available


  48. BARRETT T, Priest AN, Lawrence EM, Goldman DA, et al
    Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate.
    AJR Am J Roentgenol. 2015;205:W585-93.
    PubMed     Text format     Abstract available


    October 2015
  49. WESTPHALEN AC, Noworolski SM, Harisinghani M, Jhaveri KS, et al
    High-Resolution 3-T Endorectal Prostate MRI: A Multireader Study of Radiologist Preference and Perceived Interpretive Quality of 2D and 3D T2-Weighted Fast Spin-Echo MR Images.
    AJR Am J Roentgenol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  50. GOENKA AH, Remer EM, Veniero JC, Thupili CR, et al
    CT-Guided Transgluteal Biopsy for Systematic Random Sampling of the Prostate in Patients Without Rectal Access.
    AJR Am J Roentgenol. 2015;205:578-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: